Cardiovascular Systems Reports Fiscal 2015 Fourth-Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Needham & Company Cuts Price Target on Cardiovascular Systems (CSII) to $37 Following 4Q15 Results
August 6, 2015 7:41 AM EDTNeedham & Company maintained a Strong Buy on Cardiovascular Systems (NASDAQ: CSII), and cut the price target to $37.00 (from $45.00), following 4Q15 results. Revenue was $48.5M (up 22.5% Y/Y) vs. consensus of $50.1M. EPS was ($0.27) vs. consensus of ($0.30). For F1Q16, CSII expects revenue of $48.5-50.0M vs.... More
Cardiovascular Systems (CSII) Tops Q4 EPS by 3c
August 5, 2015 4:01 PM EDTCardiovascular Systems (NASDAQ: CSII) reported Q4 EPS of ($0.27), $0.03 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $48.5 million versus the consensus estimate of $50.1 million.
David L. Martin, CSIs President and Chief Executive Officer, said, Significant progress continued on... More
